# CHEMOTHERAPY REGIMENS EXCEL TEMPLATE
# This file shows the structure for each sheet in the Excel template
# Save as separate sheets in Excel workbook

# ==========================================
# SHEET 1: REGIMENS (Main Data)
# ==========================================
Regimen_ID,Name,Description,Category,Line_of_Therapy,Schedule,Cycles,Mechanism_of_Action,Overall_Response_Rate,Progression_Free_Survival,ECOG_Status_Required,Contraindications,Clinical_Trials
FOLFOX-mCRC-1L,FOLFOX,Oxaliplatin + 5-FU + Leucovorin for metastatic colorectal cancer,metastatic,first-line,Every 2 weeks,12,DNA crosslinking + antimetabolite,45-50%,9.4 months,"0,1,2","Severe neuropathy, severe renal impairment",NCT12345678
FOLFIRI-mCRC-2L,FOLFIRI,Irinotecan + 5-FU + Leucovorin for second-line metastatic colorectal cancer,metastatic,second-line,Every 2 weeks,12,Topoisomerase I inhibition + antimetabolite,35-40%,6.2 months,"0,1,2","Severe diarrhea history, UGT1A1*28 homozygous",NCT23456789
CAPOX-adj,CAPOX,Capecitabine + Oxaliplatin adjuvant therapy,adjuvant,first-line,Every 3 weeks,8,Oral fluoropyrimidine + platinum agent,N/A,N/A,"0,1","DPD deficiency, severe renal impairment",NCT34567890

# ==========================================
# SHEET 2: DRUGS
# ==========================================
Regimen_ID,Drug_Name,Dosage,Unit,Route,Day,Drug_Class,Administration_Duration,Dilution,Monitoring,Notes
FOLFOX-mCRC-1L,Oxaliplatin,85,mg/m2,IV,1,chemotherapy,2 hours,250-500ml D5W,"CBC, CMP, neuropathy assessment",Pre-filter required
FOLFOX-mCRC-1L,Leucovorin,400,mg/m2,IV,1,chemotherapy,2 hours,250ml NS or D5W,None,Give before 5-FU
FOLFOX-mCRC-1L,5-Fluorouracil,400,mg/m2,IV bolus,1,chemotherapy,Push,NS flush,None,Give after leucovorin
FOLFOX-mCRC-1L,5-Fluorouracil,2400,mg/m2,IV continuous,1-2,chemotherapy,46 hours,Ambulatory pump,Monitor pump function,Requires central access
FOLFIRI-mCRC-2L,Irinotecan,180,mg/m2,IV,1,chemotherapy,90 minutes,250-500ml D5W,"CBC, bilirubin, diarrhea",UGT1A1 testing recommended
FOLFIRI-mCRC-2L,Leucovorin,400,mg/m2,IV,1,chemotherapy,2 hours,250ml NS or D5W,None,Give before 5-FU
FOLFIRI-mCRC-2L,5-Fluorouracil,400,mg/m2,IV bolus,1,chemotherapy,Push,NS flush,None,Give after leucovorin
FOLFIRI-mCRC-2L,5-Fluorouracil,2400,mg/m2,IV continuous,1-2,chemotherapy,46 hours,Ambulatory pump,Monitor pump function,Requires central access
CAPOX-adj,Capecitabine,1000,mg/m2,PO,1-14,chemotherapy,N/A,N/A,"CBC, hand-foot syndrome, diarrhea",Take with food
CAPOX-adj,Oxaliplatin,130,mg/m2,IV,1,chemotherapy,2 hours,250-500ml D5W,"CBC, CMP, neuropathy assessment",Pre-filter required

# ==========================================
# SHEET 3: PREMEDICATIONS
# ==========================================
Regimen_ID,Medication_Name,Dosage,Unit,Route,Category,Timing,Indication,Is_Required,Is_Standard,Administration_Duration,Weight_Based,Notes
FOLFOX-mCRC-1L,Ondansetron,8,mg,IV,antiemetic,30 min before,Nausea/vomiting prophylaxis,TRUE,TRUE,Push,FALSE,Standard antiemetic
FOLFOX-mCRC-1L,Dexamethasone,12,mg,IV,corticosteroid,30 min before,Nausea/vomiting prophylaxis,TRUE,TRUE,Push,FALSE,Enhances antiemetic effect
FOLFOX-mCRC-1L,Diphenhydramine,25,mg,IV,antihistamine,30 min before,Hypersensitivity prophylaxis,FALSE,TRUE,Push,FALSE,For oxaliplatin reactions
FOLFIRI-mCRC-2L,Ondansetron,8,mg,IV,antiemetic,30 min before,Nausea/vomiting prophylaxis,TRUE,TRUE,Push,FALSE,Standard antiemetic
FOLFIRI-mCRC-2L,Dexamethasone,12,mg,IV,corticosteroid,30 min before,Nausea/vomiting prophylaxis,TRUE,TRUE,Push,FALSE,Enhances antiemetic effect
FOLFIRI-mCRC-2L,Atropine,0.25,mg,IV,other,Before irinotecan,Cholinergic syndrome prevention,TRUE,TRUE,Push,FALSE,For early diarrhea
CAPOX-adj,Ondansetron,8,mg,PO,antiemetic,30 min before,Nausea/vomiting prophylaxis,TRUE,TRUE,N/A,FALSE,Oral form acceptable
CAPOX-adj,Dexamethasone,8,mg,PO,corticosteroid,30 min before,Nausea/vomiting prophylaxis,TRUE,TRUE,N/A,FALSE,Lower dose for oral route

# ==========================================
# SHEET 4: BIOMARKERS
# ==========================================
Regimen_ID,Biomarker_Name,Status_Required,Testing_Method,Threshold,Is_Required,Turnaround_Time,Notes
FOLFOX-mCRC-1L,UGT1A1,wild-type,PCR,*1/*1 or *1/*28,FALSE,3-5 days,Optional for 5-FU toxicity prediction
FOLFIRI-mCRC-2L,UGT1A1,wild-type,PCR,*1/*1 or *1/*28,TRUE,3-5 days,Required due to irinotecan toxicity risk
FOLFIRI-mCRC-2L,DPD,normal,Enzyme assay,>0.1 nmol/min/mg,FALSE,5-7 days,Consider if 5-FU toxicity history
CAPOX-adj,DPD,normal,Enzyme assay,>0.1 nmol/min/mg,FALSE,5-7 days,Optional for capecitabine safety
CAPOX-adj,KRAS,any,NGS,N/A,FALSE,7-10 days,Prognostic marker only

# ==========================================
# SHEET 5: DRUG_INTERACTIONS
# ==========================================
Regimen_ID,Interacting_Drug,Severity,Effect,Management
FOLFOX-mCRC-1L,Warfarin,major,Increased bleeding risk,Monitor INR closely; consider dose adjustment
FOLFOX-mCRC-1L,Phenytoin,moderate,Altered phenytoin levels,Monitor levels; adjust dose as needed
FOLFIRI-mCRC-2L,St John's Wort,major,Reduced irinotecan efficacy,Avoid concurrent use
FOLFIRI-mCRC-2L,CYP3A4 inhibitors,moderate,Increased toxicity,Monitor for increased side effects
CAPOX-adj,Coumadin,major,Enhanced anticoagulation,Monitor INR; reduce anticoagulant dose

# ==========================================
# SHEET 6: REFERENCE_DATA (Dropdown Lists)
# ==========================================
# Use these standardized values for data validation

Categories:
neoadjuvant,adjuvant,advanced,metastatic

Lines_of_Therapy:
first-line,second-line,third-line,maintenance,salvage

Drug_Classes:
chemotherapy,targeted,immunotherapy,hormone,supportive

Routes:
IV,PO,SC,IM,IT

Premedication_Categories:
antiemetic,corticosteroid,antihistamine,h2_blocker,bronchodilator,other

Biomarker_Status:
positive,negative,wild-type,mutated,amplified,high,low,unknown

Interaction_Severity:
major,moderate,minor

ECOG_Status:
0,1,2,3,4

# ==========================================
# SHEET 7: INSTRUCTIONS
# ==========================================
# INSTRUCTIONS FOR COMPLETING THE TEMPLATE

GENERAL GUIDELINES:
1. Each regimen must have a unique Regimen_ID
2. Use the Reference_Data sheet for standardized dropdown values
3. All required fields must be completed
4. Dosages should include appropriate units
5. Use semicolons to separate multiple values in single cells

REGIMENS SHEET:
- Regimen_ID: Unique identifier (use format: REGIMEN-CATEGORY-LINE)
- Name: Standard regimen name
- Category: neoadjuvant, adjuvant, advanced, or metastatic
- Line_of_Therapy: first-line, second-line, third-line, maintenance, or salvage
- ECOG_Status_Required: Comma-separated list (e.g., "0,1,2")
- Contraindications: Semicolon-separated list

DRUGS SHEET:
- Link drugs to regimens using Regimen_ID
- Include all drugs in the regimen
- Specify day of administration for multi-day cycles
- Include monitoring requirements

PREMEDICATIONS SHEET:
- Link to regimens using Regimen_ID
- Specify timing relative to chemotherapy
- Mark required vs. optional medications
- Include rationale for each premedication

BIOMARKERS SHEET:
- Link to regimens using Regimen_ID
- Specify required vs. optional testing
- Include testing methodology and thresholds

VALIDATION RULES:
- All Regimen_IDs must be unique
- Required fields cannot be empty
- Numeric fields must contain valid numbers
- Use only approved values from Reference_Data

IMPORT PROCESS:
1. Complete all sheets with your regimen data
2. Validate data against reference lists
3. Save as Excel workbook (.xlsx)
4. Upload file to the application
5. Review imported data before final approval